-
JM Financial Products
Attractive yield notwithstanding, penchant for lending to real estate developers for acquisition of land parcels is fraught with considerable risk.
-
Paras Defence and Space Technologies
Stagnant revenue and receding bottom line in the face of bulging equity coupled with optimum pricing leaves little room for capital appreciation
-
Vijaya Diagnostic Centre
Listed group company Medinova Diagnostic’s contrasting track reveals promoter’s intent!
-
Ami Organics’ IPO `chemistry’ changes
In July 2018, when Sensex was hovering around 36200, Surat-based Ami Organics filed the draft red herring prospectus for its IPO. That time, it intended to raise about Rs 100 cr by offering 35 lakh shares.
-
Indian citizen without Aadhaar Card!
Not long ago, after creating the Vedanta umbrellain the UK, Anil Agarwalof Sterlite-fame tried to emit the Indian investing public from his domestic companies by uncommon and questionable means
-
Aptus Value Housing Finance
Core promoter’s unassuming stake, lack of succession plan, steep IPO-pricing and post-pandemic court rulings weigh against the scrip
-
Chemplast Sanmar
Previous `listed track’, recurrent `scheme of arrangement’ and unscrupulous way of ejecting minority shareholders make it below investible grade
